Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation
for Relapsed or Refractory Acute Myeloid Leukemia (AML)
26 locations incl. Birmingham
Sponsor: Institut de Recherches Internationales Servier
Sex: All·Age: 18+
Code: NCT02074839·Phase 1·Recruiting